首页> 外文期刊>Bio-Design and Manufacturing >Innovation leading development: a glimpse into three-dimensional bioprinting in Israel
【24h】

Innovation leading development: a glimpse into three-dimensional bioprinting in Israel

机译:创新引领发展:以色列三维生物打印一瞥

获取原文
获取原文并翻译 | 示例

摘要

Three-dimensional (3D) printing has attracted increasing research interest as an emerging manufacturing technology for developing sophisticated and exquisite architecture through hierarchical printing. It has also been employed in various advanced industrial areas. The development of intelligent biomedical engineering has raised the requirements for 3D printing, such as flexible manufacturing processes and technologies, biocompatible constituents, and alternative bioproducts. However, state-of-the-art 3D printing mainly involves inorganics or polymers and generally focuses on traditional industrial fields, thus severely limiting applications demanding biocompatibility and biodegradability. In this regard, peptide architectonics, which are self-assembled by programmed amino acid sequences that can be flexibly functionalized, have shown promising potential as bioinspired inks for 3D printing. Therefore, the combination of 3D printing and peptide self-assembly potentially opens up an alternative avenue of 3D bioprinting for diverse advanced applications. Israel, a small but innovative nation, has significantly contributed to 3D bioprinting in terms of scientific studies, marketization, and peptide architectonics, including modulations and applications, and ranks as a leading area in the 3D bioprinting field. This review summarizes the recent progress in 3D bioprinting in Israel, focusing on scientific studies on printable components, soft devices, and tissue engineering. This paper further delves into the manufacture of industrial products, such as artificial meats and bioinspired supramolecular architectures, and the mechanisms, physicochemical properties, and applications of peptide self-assembly. Undoubtedly, Israel contributes significantly to the field of 3D bioprinting and should thus be appropriately recognized.
机译:3D 打印作为一种新兴的制造技术,通过分层打印开发复杂而精致的建筑,引起了越来越多的研究兴趣。它还被用于各种先进的工业领域。智能生物医学工程的发展提高了对 3D 打印的要求,例如灵活的制造工艺和技术、生物相容性成分和替代生物制品。然而,最先进的 3D 打印主要涉及无机物或聚合物,并且通常集中在传统的工业领域,从而严重限制了需要生物相容性和生物降解性的应用。在这方面,由可编程氨基酸序列自组装的肽结构学可以灵活功能化,作为 3D 打印的生物启发墨水已显示出广阔的潜力。因此,3D 打印和肽自组装的结合有可能为各种高级应用开辟 3D 生物打印的替代途径。以色列是一个小而创新的国家,在科学研究、市场化和多肽结构学(包括调节和应用)方面为 3D 生物打印做出了重大贡献,并在 3D 生物打印领域处于领先地位。本文总结了以色列 3D 生物打印的最新进展,重点介绍了可打印组件、软设备和组织工程的科学研究。本文进一步深入研究了工业产品的制造,例如人造肉和仿生超分子结构,以及肽自组装的机制、物理化学性质和应用。毫无疑问,以色列对 3D 生物打印领域做出了重大贡献,因此应该得到适当的认可。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号